IMMUNOHISTOCHEMICAL DETECTION OF L CELLS IN GASTROINTESTINAL TRACT MUCOSA OF PATIENTS AFTER SURGICAL TREATMENT FOR CONTROL OF TYPE 2 DIABETES MELLITUS

ABSTRACT - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a disease of global impact that has led to an increase in comorbidities and mortality in several countries. Immunoexpression of the incretin hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY (3-36) (PYY3-36) can be used as a scorer in the gastrointestinal tract to analyze L-cell activity in response to T2DM treatment. OBJECTIVE: This study aimed to investigate the presence, location, and secretion of L cells in the small intestine of patients undergoing the form of bariatric surgery denominated adaptive gastroenteromentectomy with partial bipartition. METHODS: Immunohistochemical assays, quantitative real-time polymerase chain reaction (qPCR), and Western blot analysis were performed on samples of intestinal mucosa from patients with T2DM in both the preoperative and postoperative periods. RESULTS: All results were consistent and indicated basal expression and secretion of GLP-1 and PYY3-36 incretins by L cells. A greater density of cells was demonstrated in the most distal portions of the small intestine. No significant difference was found between GLP-1 and PYY3-36 expression levels in the preoperative and postoperative periods because of prolonged fasting during which the samples were collected. CONCLUSION: The greater number of L cells in activity implies better peptide signaling, response, and functioning of the neuroendocrine system.

Saved in:
Bibliographic Details
Main Authors: ESTABILE,Priscila Costa, ALMEIDA,Mara Cristina de, CAMPAGNOLI,Eduardo Bauml, SANTO,Marco Aurelio, RODRIGUES,Marcos Ricardo da Silva, MILLÉO,Fábio Quirillo, ARTONI,Roberto Ferreira
Format: Digital revista
Language:English
Published: Colégio Brasileiro de Cirurgia Digestiva 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202022000100307
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0102-67202022000100307
record_format ojs
spelling oai:scielo:S0102-672020220001003072022-06-14IMMUNOHISTOCHEMICAL DETECTION OF L CELLS IN GASTROINTESTINAL TRACT MUCOSA OF PATIENTS AFTER SURGICAL TREATMENT FOR CONTROL OF TYPE 2 DIABETES MELLITUSESTABILE,Priscila CostaALMEIDA,Mara Cristina deCAMPAGNOLI,Eduardo BaumlSANTO,Marco AurelioRODRIGUES,Marcos Ricardo da SilvaMILLÉO,Fábio QuirilloARTONI,Roberto Ferreira Type 2 Diabetes Mellitus Bariatric Surgery Obesity Incretins Glucagon-Like Peptide-1 ABSTRACT - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a disease of global impact that has led to an increase in comorbidities and mortality in several countries. Immunoexpression of the incretin hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY (3-36) (PYY3-36) can be used as a scorer in the gastrointestinal tract to analyze L-cell activity in response to T2DM treatment. OBJECTIVE: This study aimed to investigate the presence, location, and secretion of L cells in the small intestine of patients undergoing the form of bariatric surgery denominated adaptive gastroenteromentectomy with partial bipartition. METHODS: Immunohistochemical assays, quantitative real-time polymerase chain reaction (qPCR), and Western blot analysis were performed on samples of intestinal mucosa from patients with T2DM in both the preoperative and postoperative periods. RESULTS: All results were consistent and indicated basal expression and secretion of GLP-1 and PYY3-36 incretins by L cells. A greater density of cells was demonstrated in the most distal portions of the small intestine. No significant difference was found between GLP-1 and PYY3-36 expression levels in the preoperative and postoperative periods because of prolonged fasting during which the samples were collected. CONCLUSION: The greater number of L cells in activity implies better peptide signaling, response, and functioning of the neuroendocrine system.info:eu-repo/semantics/openAccessColégio Brasileiro de Cirurgia DigestivaABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.35 20222022-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202022000100307en10.1590/0102-672020210002e1651
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author ESTABILE,Priscila Costa
ALMEIDA,Mara Cristina de
CAMPAGNOLI,Eduardo Bauml
SANTO,Marco Aurelio
RODRIGUES,Marcos Ricardo da Silva
MILLÉO,Fábio Quirillo
ARTONI,Roberto Ferreira
spellingShingle ESTABILE,Priscila Costa
ALMEIDA,Mara Cristina de
CAMPAGNOLI,Eduardo Bauml
SANTO,Marco Aurelio
RODRIGUES,Marcos Ricardo da Silva
MILLÉO,Fábio Quirillo
ARTONI,Roberto Ferreira
IMMUNOHISTOCHEMICAL DETECTION OF L CELLS IN GASTROINTESTINAL TRACT MUCOSA OF PATIENTS AFTER SURGICAL TREATMENT FOR CONTROL OF TYPE 2 DIABETES MELLITUS
author_facet ESTABILE,Priscila Costa
ALMEIDA,Mara Cristina de
CAMPAGNOLI,Eduardo Bauml
SANTO,Marco Aurelio
RODRIGUES,Marcos Ricardo da Silva
MILLÉO,Fábio Quirillo
ARTONI,Roberto Ferreira
author_sort ESTABILE,Priscila Costa
title IMMUNOHISTOCHEMICAL DETECTION OF L CELLS IN GASTROINTESTINAL TRACT MUCOSA OF PATIENTS AFTER SURGICAL TREATMENT FOR CONTROL OF TYPE 2 DIABETES MELLITUS
title_short IMMUNOHISTOCHEMICAL DETECTION OF L CELLS IN GASTROINTESTINAL TRACT MUCOSA OF PATIENTS AFTER SURGICAL TREATMENT FOR CONTROL OF TYPE 2 DIABETES MELLITUS
title_full IMMUNOHISTOCHEMICAL DETECTION OF L CELLS IN GASTROINTESTINAL TRACT MUCOSA OF PATIENTS AFTER SURGICAL TREATMENT FOR CONTROL OF TYPE 2 DIABETES MELLITUS
title_fullStr IMMUNOHISTOCHEMICAL DETECTION OF L CELLS IN GASTROINTESTINAL TRACT MUCOSA OF PATIENTS AFTER SURGICAL TREATMENT FOR CONTROL OF TYPE 2 DIABETES MELLITUS
title_full_unstemmed IMMUNOHISTOCHEMICAL DETECTION OF L CELLS IN GASTROINTESTINAL TRACT MUCOSA OF PATIENTS AFTER SURGICAL TREATMENT FOR CONTROL OF TYPE 2 DIABETES MELLITUS
title_sort immunohistochemical detection of l cells in gastrointestinal tract mucosa of patients after surgical treatment for control of type 2 diabetes mellitus
description ABSTRACT - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a disease of global impact that has led to an increase in comorbidities and mortality in several countries. Immunoexpression of the incretin hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY (3-36) (PYY3-36) can be used as a scorer in the gastrointestinal tract to analyze L-cell activity in response to T2DM treatment. OBJECTIVE: This study aimed to investigate the presence, location, and secretion of L cells in the small intestine of patients undergoing the form of bariatric surgery denominated adaptive gastroenteromentectomy with partial bipartition. METHODS: Immunohistochemical assays, quantitative real-time polymerase chain reaction (qPCR), and Western blot analysis were performed on samples of intestinal mucosa from patients with T2DM in both the preoperative and postoperative periods. RESULTS: All results were consistent and indicated basal expression and secretion of GLP-1 and PYY3-36 incretins by L cells. A greater density of cells was demonstrated in the most distal portions of the small intestine. No significant difference was found between GLP-1 and PYY3-36 expression levels in the preoperative and postoperative periods because of prolonged fasting during which the samples were collected. CONCLUSION: The greater number of L cells in activity implies better peptide signaling, response, and functioning of the neuroendocrine system.
publisher Colégio Brasileiro de Cirurgia Digestiva
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202022000100307
work_keys_str_mv AT estabilepriscilacosta immunohistochemicaldetectionoflcellsingastrointestinaltractmucosaofpatientsaftersurgicaltreatmentforcontroloftype2diabetesmellitus
AT almeidamaracristinade immunohistochemicaldetectionoflcellsingastrointestinaltractmucosaofpatientsaftersurgicaltreatmentforcontroloftype2diabetesmellitus
AT campagnolieduardobauml immunohistochemicaldetectionoflcellsingastrointestinaltractmucosaofpatientsaftersurgicaltreatmentforcontroloftype2diabetesmellitus
AT santomarcoaurelio immunohistochemicaldetectionoflcellsingastrointestinaltractmucosaofpatientsaftersurgicaltreatmentforcontroloftype2diabetesmellitus
AT rodriguesmarcosricardodasilva immunohistochemicaldetectionoflcellsingastrointestinaltractmucosaofpatientsaftersurgicaltreatmentforcontroloftype2diabetesmellitus
AT milleofabioquirillo immunohistochemicaldetectionoflcellsingastrointestinaltractmucosaofpatientsaftersurgicaltreatmentforcontroloftype2diabetesmellitus
AT artonirobertoferreira immunohistochemicaldetectionoflcellsingastrointestinaltractmucosaofpatientsaftersurgicaltreatmentforcontroloftype2diabetesmellitus
_version_ 1756399001568018432